• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与终末期肾病患者的低小梁骨评分相关的因素。

Factors associated with low trabecular bone scores in patients with end-stage kidney disease.

机构信息

Division of Nephrology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, #56, Dongsu-Ro, Bupyung-Gu, Incheon, South Korea.

出版信息

J Bone Miner Metab. 2019 May;37(3):475-483. doi: 10.1007/s00774-018-0938-8. Epub 2018 Jun 28.

DOI:10.1007/s00774-018-0938-8
PMID:29956021
Abstract

The trabecular bone score (TBS) is a textural index that indirectly assesses bone trabecular microarchitecture using lumbar spine images obtained by dual-energy X-ray absorptiometry (DXA). This study compared the TBS of patients with end-stage kidney disease (ESKD) with that of matched controls to identify risk factors associated with a low TBS. TBS and bone mineral density (BMD) were assessed in ESKD patients (n = 76) and age- and sex-matched control subjects (n = 76) using DXA. The TBS of both groups was then compared, and risk factors associated with a low TBS (defined as ≤ 1.31) were evaluated. The mean TBS in the ESKD group was significantly lower than that in the control group (1.34 ± 0.15 vs. 1.43 ± 0.08, respectively; p < 0.001). More subjects in the ESKD group had a low TBS [34.2% (ESRD) vs. 5.3% (controls); p < 0.001]. The TBS was negatively correlated with age, alkaline phosphatase and C-reactive protein levels, and dialysis vintage, and positively correlated with BMD at the lumbar spine, femoral neck, and hip. Multivariate analysis identified lower estimated glomerular filtration rate and increased C-reactive protein levels as being significantly associated with a low TBS. In conclusion, ESKD patients had abnormal bone microarchitecture (as assessed by the TBS). The TBS was positively correlated with BMD. Renal function and inflammatory marker levels were independently associated with a low TBS. Thus, TBS may be a useful clinical tool for assessing cancellous bone connectivity in ESKD patients.

摘要

骨小梁评分(TBS)是一种纹理指数,它使用双能 X 射线吸收法(DXA)获得的腰椎图像间接评估骨小梁微结构。本研究比较了终末期肾病(ESKD)患者和匹配对照者的 TBS,以确定与 TBS 降低相关的危险因素。使用 DXA 评估 ESKD 患者(n=76)和年龄及性别匹配的对照者(n=76)的 TBS 和骨密度(BMD)。然后比较两组的 TBS,并评估与 TBS 降低(定义为≤1.31)相关的危险因素。ESKD 组的平均 TBS 明显低于对照组(分别为 1.34±0.15 和 1.43±0.08,p<0.001)。ESKD 组中 TBS 降低的患者更多[34.2%(ESRD)比 5.3%(对照组);p<0.001]。TBS 与年龄、碱性磷酸酶和 C 反应蛋白水平以及透析龄呈负相关,与腰椎、股骨颈和髋部的 BMD 呈正相关。多变量分析发现,估算肾小球滤过率降低和 C 反应蛋白水平升高与 TBS 降低显著相关。总之,ESKD 患者的骨小梁微结构异常(通过 TBS 评估)。TBS 与 BMD 呈正相关。肾功能和炎症标志物水平与 TBS 降低独立相关。因此,TBS 可能是评估 ESKD 患者松质骨连通性的有用临床工具。

相似文献

1
Factors associated with low trabecular bone scores in patients with end-stage kidney disease.与终末期肾病患者的低小梁骨评分相关的因素。
J Bone Miner Metab. 2019 May;37(3):475-483. doi: 10.1007/s00774-018-0938-8. Epub 2018 Jun 28.
2
The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.骨小梁骨评分与终末期肾病患者的骨密度、骨转换标志物和骨折患病率相关。
Osteoporos Int. 2018 Jun;29(6):1447-1455. doi: 10.1007/s00198-018-4468-y. Epub 2018 Mar 19.
3
Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.终末期肾病透析患者小梁骨评分测量的骨质量评估
J Clin Densitom. 2017 Oct-Dec;20(4):490-497. doi: 10.1016/j.jocd.2016.11.002. Epub 2016 Dec 27.
4
Chronic hemodialysis is associated with lower trabecular bone score, independent of bone mineral density: a case-control study.慢性血液透析与较低的小梁骨评分相关,与骨密度无关:一项病例对照研究。
Arch Osteoporos. 2018 Nov 13;13(1):125. doi: 10.1007/s11657-018-0541-6.
5
DXA-derived advanced hip analysis and the trabecular bone score in end-stage kidney disease secondary to type 1 diabetes.基于 DXA 的髋关节先进分析和 1 型糖尿病继发终末期肾病的小梁骨评分。
Eur J Endocrinol. 2022 Dec 5;187(6):883-892. doi: 10.1530/EJE-22-0687. Print 2022 Dec 1.
6
Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.慢性肾脏病患者肾移植时的骨密度、微结构和材料强度。
Osteoporos Int. 2017 Sep;28(9):2723-2727. doi: 10.1007/s00198-017-4065-5. Epub 2017 May 11.
7
Evaluation of trabecular bone score in patients with a distal radius fracture.桡骨远端骨折患者的小梁骨评分评估
Osteoporos Int. 2016 Dec;27(12):3559-3565. doi: 10.1007/s00198-016-3686-4. Epub 2016 Jun 24.
8
Trabecular Bone Score in Assessing Bone Mineralization Status in Children with End- Stage Renal Disease: A Promising Tool.用小梁骨评分评估终末期肾病患儿的骨矿化状态:一种很有前途的工具。
Eur J Pediatr. 2023 Nov;182(11):4957-4967. doi: 10.1007/s00431-023-05157-z. Epub 2023 Aug 23.
9
The trabecular bone score: Relationships with trabecular and cortical microarchitecture measured by HR-pQCT and histomorphometry in patients with chronic kidney disease.骨小梁评分:与 HR-pQCT 和组织形态计量学测量的慢性肾脏病患者的骨小梁和皮质微结构的关系。
Bone. 2018 Nov;116:215-220. doi: 10.1016/j.bone.2018.08.006. Epub 2018 Aug 8.
10
Trabecular bone score in patients with chronic kidney disease.慢性肾脏病患者的小梁骨评分。
Osteoporos Int. 2020 Oct;31(10):1905-1912. doi: 10.1007/s00198-020-05458-1. Epub 2020 May 21.

引用本文的文献

1
Use of 3D-DXA in the assessment of bone structure among patients with chronic kidney disease.三维双能X线吸收法在慢性肾病患者骨结构评估中的应用
Front Med (Lausanne). 2025 Feb 4;12:1471418. doi: 10.3389/fmed.2025.1471418. eCollection 2025.
2
Bibliometric analysis of publications on trabecular bone score (TBS).小梁骨评分(TBS)相关出版物的文献计量分析。
J Diabetes Metab Disord. 2023 Dec 7;23(1):699-708. doi: 10.1007/s40200-023-01338-7. eCollection 2024 Jun.
3
Utility of Trabecular Bone Score (TBS) in Bone Quality and Fracture Risk Assessment in Patients on Maintenance Dialysis.

本文引用的文献

1
Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis.血清碱性磷酸酶升高与透析患者心血管或全因死亡风险:一项荟萃分析。
Sci Rep. 2017 Oct 16;7(1):13224. doi: 10.1038/s41598-017-13387-z.
2
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.炎症可诱导慢性肾脏病患者外周血单个核细胞向破骨细胞分化:免疫和骨骼系统间的相互作用。
Nephrol Dial Transplant. 2018 Jan 1;33(1):65-75. doi: 10.1093/ndt/gfx222.
3
Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
小梁骨评分(TBS)在维持性透析患者骨质量和骨折风险评估中的应用
Front Med (Lausanne). 2022 Jan 20;8:782837. doi: 10.3389/fmed.2021.782837. eCollection 2021.
4
Fibroblast Growth Factor 23 and Klotho Are Associated With Trabecular Bone Score but Not Bone Mineral Density in the Early Stages of Chronic Kidney Disease: Results of the Cross-Sectional Study.成纤维细胞生长因子 23 和 Klotho 与慢性肾脏病早期的小梁骨评分相关,但与骨密度无关:横断面研究的结果。
Physiol Res. 2021 Nov 30;70(Suppl 1):S43-S51. doi: 10.33549/physiolres.934773.
5
Expression of Circulating MicroRNAs Linked to Bone Metabolism in Chronic Kidney Disease-Mineral and Bone Disorder.慢性肾脏病 - 矿物质和骨异常中与骨代谢相关的循环微RNA的表达
Biomedicines. 2020 Dec 12;8(12):601. doi: 10.3390/biomedicines8120601.
6
Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.骨小梁评分可能预示着血液透析患者的慢性肾脏病-矿物质和骨异常(CKD-MBD)表型:一项前瞻性观察性研究。
BMC Nephrol. 2020 Jul 25;21(1):299. doi: 10.1186/s12882-020-01944-0.
7
Sex-specific relationship between vascular calcification and incident fracture in patients with end-stage renal disease.终末期肾病患者血管钙化与新发骨折之间的性别特异性关系。
Kidney Res Clin Pract. 2020 Sep 30;39(3):344-355. doi: 10.23876/j.krcp.20.013.
8
Trabecular bone scores in young HIV-infected men: a matched case-control study.年轻HIV感染男性的小梁骨评分:一项匹配病例对照研究。
BMC Musculoskelet Disord. 2020 Feb 10;21(1):94. doi: 10.1186/s12891-020-3092-0.
2017KDIGO 慢性肾脏病-矿物质和骨异常(CKD-MBD)指南更新执行摘要:有哪些变化,以及为什么这很重要。
Kidney Int. 2017 Jul;92(1):26-36. doi: 10.1016/j.kint.2017.04.006.
4
Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.慢性肾脏病患者肾移植时的骨密度、微结构和材料强度。
Osteoporos Int. 2017 Sep;28(9):2723-2727. doi: 10.1007/s00198-017-4065-5. Epub 2017 May 11.
5
Renal Osteodystrophy or Kidney-Induced Osteoporosis?肾性骨营养不良还是肾性骨质疏松?
Curr Osteoporos Rep. 2017 Jun;15(3):194-197. doi: 10.1007/s11914-017-0364-1.
6
Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.慢性肾脏病中的骨质量:定义与诊断
Curr Osteoporos Rep. 2017 Jun;15(3):207-213. doi: 10.1007/s11914-017-0366-z.
7
Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.终末期肾病透析患者小梁骨评分测量的骨质量评估
J Clin Densitom. 2017 Oct-Dec;20(4):490-497. doi: 10.1016/j.jocd.2016.11.002. Epub 2016 Dec 27.
8
Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function.肾功能减退成人的小梁骨评分与脆性骨折发生风险
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2032-2040. doi: 10.2215/CJN.00720116. Epub 2016 Oct 24.
9
Osteoporosis and Impaired Trabecular Bone Score in Hemodialysis Patients.血液透析患者的骨质疏松与小梁骨评分受损
Kidney Blood Press Res. 2016;41(3):345-54. doi: 10.1159/000443439. Epub 2016 Jun 23.
10
Estimating residual kidney function in dialysis patients without urine collection.在不收集尿液的情况下估算透析患者的残余肾功能。
Kidney Int. 2016 May;89(5):1099-1110. doi: 10.1016/j.kint.2015.10.011. Epub 2016 Jan 21.